by Ellie Lampton | Feb 13, 2025
Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness studies, replacing clinical trials and registries BELLEVUE, Wash. – February 12, 2025 – Today, Truveta announced the expansion of Truveta Data...
by Ellie Lampton | Jan 31, 2025
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine at University of Pennsylvania BELLEVUE, Wash. – January 31, 2025 – Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor...
by Ellie Lampton | Jan 13, 2025
The Regeneron Genetics Center® will sequence up to ten million exomes, helping to accelerate drug discovery and transform patient care BELLEVUE, Wash. – January 13, 2025 – Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford...
by Ellie Lampton | Nov 20, 2024
HITRUST r2 Certification demonstrates Truveta’s relentless commitment to the highest standards of security and privacy to protect regulatory-grade data. BELLEVUE, Wash. – November 20, 2024 – Truveta announced that its platform Truveta Studio and Truveta Data have...
by Ellie Lampton | Nov 14, 2024
Researchers with more than 100 organizations use regulatory-grade Truveta Data to enable their scientifically rigorous research BELLEVUE, Wash. – November 14, 2024 –Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health...
